Facebook
X
LinkedIn
ForwardSubstance Use Disorders Management Boot Camp (May 14-15, 2026)
Overview
This training aims to enhance confidence and competencies related to the management of substance use disorders in general medical settings. Through case-based and interactive didactic content, the workshop will explore issues related to assessment, monitoring, prevention, and management in the setting of unhealthy substance use.
Intended Audience
This program is designed for physicians, physician assistants, advanced practice nurses, nurses, pharmacists, social workers, students, residents, and fellows who treat patients with opioid use disorder.
Learning Objectives
As a result of participating in this activity, learners, as members of the healthcare team, will be able to:
- Determine accurate diagnosis and initiate treatment for opioid use disorder, alcohol withdrawal, and alcohol use disorder
- Demonstrate medical management and brief counseling skills needed to to work with patients who continue to use drugs and alcohol while in treatment for use disorder
- Determine appropriate treatment plan for OUD and AUD, including the initiation and maintenance of buprenorphine therapy, alcohol withdrawal management, and MAUD.
- Develop approaches to working with and managing patients with stimulant use disorders and/or Hepatitis C.
Elements of Competence
This educational activity is designed to change learner competence and focuses on the following competencies:
- Accreditation Council for Graduate Medical Education (ACGME)/Nursing: Patient care and procedural skills, medical knowledge, interpersonal and communication skills, and professionalism.
- National Academy of Medicine (NAM)/Nursing: Provide patient/person-centered care, employ evidence-based practice, population health
- Interprofessional Education Collaborative Competencies: Values/ethics for interprofessional practice, roles and responsibilities, communication, and teams and teamwork
- Social Impact and Belonging: Engage in self-reflection and value culturally-centered care.
Practice Gaps and Needs
Opioid use disorder can be challenging to treat in the primary care or office setting. The standards, methods and best practices in prescribing Medications for Opioid Use Disorder (MOUD), in particular Buprenorphine, change regularly and healthcare teams require up to date information on these practices. Providers lack a clear understanding in how to offer MOUD, and fail to comprehend how to interpret urine toxicology screens. Additionally, providers expressed interest in more education related to the logistical challenges commonly encountered when treating patients with complex opioid use disorders.
Agenda
Thursday, May 14th | |
8:00 a.m. - 9:00 a.m. | Breakfast/Welcome/Introductions |
| 9:00- 10:30 a.m. | Opioid Use Disorder 101: Chronic Disease Management in the Age of Fentanyl Maggie Williams, MPAS, PA-C, CPAAPA |
10:30 - 10:40 a.m. | Break |
| 10:40 a.m. - 12:00 p.m. | Opioid Use Disorder Continued Maggie Williams, MPAS, PA-C, CPAAPA |
12:00 - 12:45 p.m. | Lunch |
| 12:45 - 1:30 p.m. | Extended-Release Buprenorphine Products David Leinweber, MD, MS |
| 1:30- 2:30 p.m. | Motivational Interviewing Julia Yates |
2:30 - 2:45 p.m. | Break |
| 2:45 - 4:00 p.m. | Management of Pain Margaret Gray, MD |
4:00 - 4:15 p.m. | Questions, Wrap Up |
Friday, May 15th | |
8:00 - 8:30 a.m. | Breakfast |
| 8:30 - 9:45 a.m. | Alcohol Use Disorder Randy Brown MD, PhD, DFASAM |
| 9:45 - 10:45 a.m. | Harm Reduction Services All faculty |
10:45 - 11:00 a.m. | Break |
| 11:00 - 11:30 a.m. | Stimulant Use Disorder Randy Brown MD, PhD, DFASAM |
| 11:30 a.m. - 12:00 p.m. | Urine Drug Testing David Leinweber, MD, MS |
| 12:00 - 12:30 p.m. | Lunch |
| 12:30 - 1:00 p.m. | Benzodiazepine Tapering Randy Brown MD, PhD, DFASAM |
| 1:00 - 1:45 p.m. | Peer Support and Recovery All faculty |
1:45 - 2:00 p.m. | Wrap Up |
Provided by
- University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP)
- UW-Madison School of Medicine and Public Health
- Wisconsin Department of Health Services
For additional questions, please contact Kathleen Maher, [email protected].
Learners are responsible for their own transportation and lodging.
Planning Committee
| Randy Brown MD, PhD, DFASAM, Professor, UW School of Medicine & Public Health |
| Kelly Eagen, MD, Assistant Professor, Department of Family Medicine and Community Health, Associate Program Director, Addiction Medicine Fellowship, UW-Madison School of Medicine and Public Health |
| James Eberhard, MFA, Accreditation Specialist, Office of Continuing Professional Development, UW-Madison School of Medicine and Public Health |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health |
| Jill Lindwall, MSN, RN, CPHQ, Clinical Staff Educator at University of Wisconsin Medical Foundation |
| Kathleen Maher, Outreach Specialist, Department of Family Medicine and Community Health |
| Maggie Williams, MPAS, PA-C, CPAAPA, Addiction Medicine Physician Assistant, UW Health |
Faculty
| Randy Brown MD, PhD, DFASAM, Professor, UW School of Medicine & Public Health |
| Kelly Eagen, MD, Assistant Professor, Department of Family Medicine and Community Health, Associate Program Director, Addiction Medicine Fellowship, UW-Madison School of Medicine and Public Health |
| Margaret Gray, MD, Addiction Medicine Fellow, Clinical Physician Faculty - Urgent Care, Family Medicine and Community Health Addiction Medicine, UW-Madison School of Medicine and Public Health |
| David Leinweber, MD, MS, Assistant Professor, Department of Family Medicine and Community Health |
| Robert Redwood, MD, MPH, Emergency Physician at Absaroka Emergency Physicians, Bozeman, MT |
| Maggie Williams, MPAS, PA-C, CPAAPA, Addiction Medicine Physician Assistant, UW Health |
| Cody J Wenthur, PharmD, PhD, Director, MS Program in Psychoactive Pharmaceutical Investigation, ExecComm, Transdisciplinary Center for Research in Psychoactive Substances, University of Wisconsin - Madison |
| Julia Yates, LCSW, Director of Behavioral Health and Wellbeing Program Manager, Department of Family Medicine and Community Health, University of Wisconsin Madison |
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below:
| Name | Role | Relevant Financial Relationships Disclosed | Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation? |
| Randy Brown MD, PhD, DFASAM | Clinical Director/Planning Committee Chair, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Kelly Eagen, MD | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| James Eberhard, MFA | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
| Margaret Gray, MD | Faculty | No relevant relationships with ineligible companies to disclose | No |
| David Leinweber, MD, MS | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Jill Lindwall, MSN, RN, CPHQ | Planning Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Kathleen Maher | Activity Coordinator | No relevant relationships with ineligible companies to disclose | No |
| Robert Redwood, MD, MPH | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Maggie Williams, MPAS, PA-C, CPAAPA | Planning Committee Member, Faculty | No relevant relationships with ineligible companies to disclose | No |
| Cody J Wenthur, PharmD, PhD | Planning Committee Member | No relevant relationships with ineligible companies to disclose | No |
| Julia Yates, LCSW | Faculty | No relevant relationships with ineligible companies to disclose | No |
Accreditation and Credit Designation Statements
Accreditation Logos | Accreditation Statements |
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. | |
American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 10.25 ANCC contact hours, 3.5 of which are eligible for pharmacotherapeutic contact hours. | |
 | American Academy of Physician Assistants (AAPA) The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |
Wisconsin Medical Examining Board Opioid CME This course is approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code. Course Title: Substance Use Disorders Management Boot Camp (May 14-15, 2026) | |
Medication Access and Training Expansion (MATE) Act This course is designed to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act. (Click here for more information.) | |
Accreditation Council for Pharmacy Education (ACPE) The University of Wisconsin–Madison ICEP designates this knowledge-based activity for a maximum of 10.25 hours or 1.025 of CPE credit. Credit can be earned by documented attendance and by successfully completing the evaluation. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. Universal Activity Number (UAN):JA0000358-0000-26-029-L99-P | |
Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 10.25 CEUs or 1.025 hours. |
Available Credit
- 10.25 AAPA Category 1 CME
- 10.25 ACPE Contact Hours - Pharmacist
- 10.25 AMA PRA Category 1 Credit™
- 10.25 ANCC Contact Hours
- 9.00 Wisconsin Responsible Opioid Prescribing Credit
- 2.75 ANCC Pharmacotherapy Contact Hours
- 10.25 University of Wisconsin–Madison Continuing Education Hours
- 10.25 Approved for AMA PRA Category 1 Credit™
- 10.25 Wisconsin Responsible Opioid Prescribing Credit
This activity is in-person only.
Questions about event, venue, or registration:
Email Kathleen Maher [email protected]
Questions about claiming CE credit or help with ICEP Learning Portal
Email [email protected].
Program changes
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
Accessibility
We value inclusion and access for all participants and are pleased to provide reasonable accommodation for this event. Please contact [email protected] as soon as you can make a reasonable accommodation request.
For further information
For additional questions about the conference, including accessibility requests, please contact: Kathleen Maher [email protected].